PD18: Kidney Cancer: Epidemiology & Evaluation/Staging/Surveillance II

Saturday, May 14, 2022

7:00 AM – 9:00 AM

Location: Room 255

Podium Session Moderator(s)

Pilar Laguna Pes, MD

Istanbul Medipol University
J. Stuart Wolf, Jr., MD, FACS

Dept of Surgery - Exec Assoc Chair; Assoc Chair for Clinical Operations; Chief,
Dell Medical School of The University of Texas at Austin

Presentations:

7:40 AM – 7:50 AM

PD18-05: Clinical Characteristics and Risk Factors for Survival in Affected Offspring of von Hippel-Lindau Disease Patients
Podium Presenter: kenan Zhang
7:50 AM – 8:00 AM

PD18-06: Nephrometry scores predicting value of Trifecta achievement in a multicenter analysis (ROSULA database) of Robotic Partial Nephrectomy for totally endophytic deep renal masses
Podium Presenter: Gabriele Tuderti, PhD – "Regina Elena" National Cancer Institute, Dept. of
8:00 AM – 8:10 AM

PD18-07: Performance of GFR calculators: CKD-EPI 2021, CKD-EPI 2009, and MDRD in estimation of kidney function prior to nephrectomy
Podium Presenter: Maria B. Antony, BS
8:10 AM – 8:20 AM

PD18-08: Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Small Renal Cell Carcinomas After Image-Guided Cryoablation (CRYO) or Radio-Frequency Ablation (RFA)
Podium Presenter: Aqua Asif, BS
8:20 AM – 8:30 AM

PD18-09: A novel prognostic biomarker to predict tumor mutation burden based on deep learning from slide images
Podium Presenter: Jian Lu, MD – Peking University Third Hospital
8:30 AM – 8:40 AM

PD18-10: Germline Testing in Renal Cell Carcinoma : Can Enrichment Features Help Predict Germline Alterations?
Podium Presenter: Alexis Rompre-Brodeur
8:40 AM – 8:50 AM

PD18-11: First In-Human Results of ⁶⁸Ga-EMP-100 PET for Imaging c-MET Expression in Renal Cell Carcinoma
Podium Presenter: Michael D. Staehler, MD
8:50 AM – 9:00 AM

PD18-12: Investigation of Race and Associated Socioeconomic Factors in Survival Outcomes for Patients with Renal Cell Carcinoma
Podium Presenter: Ridwan I. Alam, MD,MPH